Selected research
Market Structure
Global AI Drug Target Discovery Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI Drug Target Discovery Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI Drug Target Discovery Service include Exscientia, Atomwise, Benevolent AI, Insitro, Xaira Therapeutics, Tempus AI, AbCellera, Recursion and Iktos, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI Drug Target Discovery Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Drug Target Discovery Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Drug Target Discovery Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Drug Target Discovery Service market size, projected growth trends, production technologies, key applications, and end-use industries.
AI Drug Target Discovery Service Segment by Company
Exscientia
Atomwise
Benevolent AI
Insitro
Xaira Therapeutics
Tempus AI
AbCellera
Recursion
Iktos
Genialis
Anima Biotech
BPGbio
Cradle
Isomorphic Labs
Generate Biomedicines
Latent Labs
Relay Therapeutics
Model Medicines
Nimbus Therapeutics
Schrödinger
XtalPi
Insilico Medicine
Drug Farm
BioMap
AI Drug Target Discovery Service Segment by Type
Target Identification Based on Omics Data and Biological Networks
Target Mining Based on Literature and Knowledge Graphs
Target Prediction Based on Structural Bioinformatics
Target Discovery Based on Phenotypic Screening and Virtual Patients
AI Drug Target Discovery Service Segment by Application
Pharmaceutical Company
CRO and Universities
Others
AI Drug Target Discovery Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Target Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Target Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Target Discovery Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Drug Target Discovery Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Target Discovery Service industry.
Chapter 3: Detailed analysis of AI Drug Target Discovery Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Target Discovery Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Target Identification Based on Omics Data and Biological Networks
- Target Mining Based on Literature and Knowledge Graphs
- Target Prediction Based on Structural Bioinformatics
- Target Discovery Based on Phenotypic Screening and Virtual Patients
Applications
- Pharmaceutical Company
- CRO and Universities
- Others
Companies covered
- Exscientia
- Atomwise
- Benevolent AI
- Insitro
- Xaira Therapeutics
- Tempus AI
- AbCellera
- Recursion
- Iktos
- Genialis
- Anima Biotech
- BPGbio
- Cradle
- Isomorphic Labs
- Generate Biomedicines
- Latent Labs
- Relay Therapeutics
- Model Medicines
- Nimbus Therapeutics
- Schrödinger
- XtalPi
- Insilico Medicine
- Drug Farm
- BioMap
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI Drug Target Discovery Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Target Identification Based on Omics Data and Biological Networks
- 1.2.3 Target Mining Based on Literature and Knowledge Graphs
- 1.2.4 Target Prediction Based on Structural Bioinformatics
- 1.2.5 Target Discovery Based on Phenotypic Screening and Virtual Patients
- 1.3 Market Analysis by Application
- 1.3.1 Global AI Drug Target Discovery Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Company
- 1.3.3 CRO and Universities
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global AI Drug Target Discovery Service Growth Trends by Region
- 1.5.1 Global AI Drug Target Discovery Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI Drug Target Discovery Service Market Size by Region (2021-2026)
- 1.5.3 AI Drug Target Discovery Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI Drug Target Discovery Service Market Dynamics
- 2.1 AI Drug Target Discovery Service Industry Trends
- 2.2 AI Drug Target Discovery Service Industry Drivers
- 2.3 AI Drug Target Discovery Service Industry Opportunities and Challenges
- 2.4 AI Drug Target Discovery Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI Drug Target Discovery Service Revenue by Company (2021-2026)
- 3.2 Global AI Drug Target Discovery Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI Drug Target Discovery Service Key Company Head office and Area Served
- 3.4 Global AI Drug Target Discovery Service Company, Product Type & Application
- 3.5 Global AI Drug Target Discovery Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI Drug Target Discovery Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI Drug Target Discovery Service Players Market Share by Revenue in 2025
- 3.6.3 2025 AI Drug Target Discovery Service Tier 1, Tier 2, and Tier 3
4 AI Drug Target Discovery Service Market by Type
- 4.1 Global AI Drug Target Discovery Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI Drug Target Discovery Service Market Size by Type (2021-2032)
- 4.3 Global AI Drug Target Discovery Service Market Size Share by Type (2021-2032)
5 AI Drug Target Discovery Service Market by Application
- 5.1 Global AI Drug Target Discovery Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI Drug Target Discovery Service Market Size by Application (2021-2032)
- 5.3 Global AI Drug Target Discovery Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Exscientia
- 6.1.1 Exscientia Company Information
- 6.1.2 Exscientia Business Overview
- 6.1.3 Exscientia AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Exscientia AI Drug Target Discovery Service Product Portfolio
- 6.1.5 Exscientia Recent Developments
- 6.2 Atomwise
- 6.2.1 Atomwise Company Information
- 6.2.2 Atomwise Business Overview
- 6.2.3 Atomwise AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Atomwise AI Drug Target Discovery Service Product Portfolio
- 6.2.5 Atomwise Recent Developments
- 6.3 Benevolent AI
- 6.3.1 Benevolent AI Company Information
- 6.3.2 Benevolent AI Business Overview
- 6.3.3 Benevolent AI AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Benevolent AI AI Drug Target Discovery Service Product Portfolio
- 6.3.5 Benevolent AI Recent Developments
- 6.4 Insitro
- 6.4.1 Insitro Company Information
- 6.4.2 Insitro Business Overview
- 6.4.3 Insitro AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Insitro AI Drug Target Discovery Service Product Portfolio
- 6.4.5 Insitro Recent Developments
- 6.5 Xaira Therapeutics
- 6.5.1 Xaira Therapeutics Company Information
- 6.5.2 Xaira Therapeutics Business Overview
- 6.5.3 Xaira Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Xaira Therapeutics AI Drug Target Discovery Service Product Portfolio
- 6.5.5 Xaira Therapeutics Recent Developments
- 6.6 Tempus AI
- 6.6.1 Tempus AI Company Information
- 6.6.2 Tempus AI Business Overview
- 6.6.3 Tempus AI AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Tempus AI AI Drug Target Discovery Service Product Portfolio
- 6.6.5 Tempus AI Recent Developments
- 6.7 AbCellera
- 6.7.1 AbCellera Company Information
- 6.7.2 AbCellera Business Overview
- 6.7.3 AbCellera AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 AbCellera AI Drug Target Discovery Service Product Portfolio
- 6.7.5 AbCellera Recent Developments
- 6.8 Recursion
- 6.8.1 Recursion Company Information
- 6.8.2 Recursion Business Overview
- 6.8.3 Recursion AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Recursion AI Drug Target Discovery Service Product Portfolio
- 6.8.5 Recursion Recent Developments
- 6.9 Iktos
- 6.9.1 Iktos Company Information
- 6.9.2 Iktos Business Overview
- 6.9.3 Iktos AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Iktos AI Drug Target Discovery Service Product Portfolio
- 6.9.5 Iktos Recent Developments
- 6.10 Genialis
- 6.10.1 Genialis Company Information
- 6.10.2 Genialis Business Overview
- 6.10.3 Genialis AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Genialis AI Drug Target Discovery Service Product Portfolio
- 6.10.5 Genialis Recent Developments
- 6.11 Anima Biotech
- 6.11.1 Anima Biotech Company Information
- 6.11.2 Anima Biotech Business Overview
- 6.11.3 Anima Biotech AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Anima Biotech AI Drug Target Discovery Service Product Portfolio
- 6.11.5 Anima Biotech Recent Developments
- 6.12 BPGbio
- 6.12.1 BPGbio Company Information
- 6.12.2 BPGbio Business Overview
- 6.12.3 BPGbio AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 BPGbio AI Drug Target Discovery Service Product Portfolio
- 6.12.5 BPGbio Recent Developments
- 6.13 Cradle
- 6.13.1 Cradle Company Information
- 6.13.2 Cradle Business Overview
- 6.13.3 Cradle AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Cradle AI Drug Target Discovery Service Product Portfolio
- 6.13.5 Cradle Recent Developments
- 6.14 Isomorphic Labs
- 6.14.1 Isomorphic Labs Company Information
- 6.14.2 Isomorphic Labs Business Overview
- 6.14.3 Isomorphic Labs AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Isomorphic Labs AI Drug Target Discovery Service Product Portfolio
- 6.14.5 Isomorphic Labs Recent Developments
- 6.15 Generate Biomedicines
- 6.15.1 Generate Biomedicines Company Information
- 6.15.2 Generate Biomedicines Business Overview
- 6.15.3 Generate Biomedicines AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Generate Biomedicines AI Drug Target Discovery Service Product Portfolio
- 6.15.5 Generate Biomedicines Recent Developments
- 6.16 Latent Labs
- 6.16.1 Latent Labs Company Information
- 6.16.2 Latent Labs Business Overview
- 6.16.3 Latent Labs AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Latent Labs AI Drug Target Discovery Service Product Portfolio
- 6.16.5 Latent Labs Recent Developments
- 6.17 Relay Therapeutics
- 6.17.1 Relay Therapeutics Company Information
- 6.17.2 Relay Therapeutics Business Overview
- 6.17.3 Relay Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Relay Therapeutics AI Drug Target Discovery Service Product Portfolio
- 6.17.5 Relay Therapeutics Recent Developments
- 6.18 Model Medicines
- 6.18.1 Model Medicines Company Information
- 6.18.2 Model Medicines Business Overview
- 6.18.3 Model Medicines AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Model Medicines AI Drug Target Discovery Service Product Portfolio
- 6.18.5 Model Medicines Recent Developments
- 6.19 Nimbus Therapeutics
- 6.19.1 Nimbus Therapeutics Company Information
- 6.19.2 Nimbus Therapeutics Business Overview
- 6.19.3 Nimbus Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Nimbus Therapeutics AI Drug Target Discovery Service Product Portfolio
- 6.19.5 Nimbus Therapeutics Recent Developments
- 6.20 Schrödinger
- 6.20.1 Schrödinger Company Information
- 6.20.2 Schrödinger Business Overview
- 6.20.3 Schrödinger AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Schrödinger AI Drug Target Discovery Service Product Portfolio
- 6.20.5 Schrödinger Recent Developments
- 6.21 XtalPi
- 6.21.1 XtalPi Company Information
- 6.21.2 XtalPi Business Overview
- 6.21.3 XtalPi AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 XtalPi AI Drug Target Discovery Service Product Portfolio
- 6.21.5 XtalPi Recent Developments
- 6.22 Insilico Medicine
- 6.22.1 Insilico Medicine Company Information
- 6.22.2 Insilico Medicine Business Overview
- 6.22.3 Insilico Medicine AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 Insilico Medicine AI Drug Target Discovery Service Product Portfolio
- 6.22.5 Insilico Medicine Recent Developments
- 6.23 Drug Farm
- 6.23.1 Drug Farm Company Information
- 6.23.2 Drug Farm Business Overview
- 6.23.3 Drug Farm AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.23.4 Drug Farm AI Drug Target Discovery Service Product Portfolio
- 6.23.5 Drug Farm Recent Developments
- 6.24 BioMap
- 6.24.1 BioMap Company Information
- 6.24.2 BioMap Business Overview
- 6.24.3 BioMap AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.24.4 BioMap AI Drug Target Discovery Service Product Portfolio
- 6.24.5 BioMap Recent Developments
7 North America
- 7.1 North America AI Drug Target Discovery Service Market Size (2021-2032)
- 7.2 North America AI Drug Target Discovery Service Market Size by Type
- 7.2.1 North America AI Drug Target Discovery Service Market Size by Type (2021-2026)
- 7.2.2 North America AI Drug Target Discovery Service Market Size by Type (2027-2032)
- 7.2.3 North America AI Drug Target Discovery Service Market Share by Type (2021-2032)
- 7.3 North America AI Drug Target Discovery Service Market Size by Application
- 7.3.1 North America AI Drug Target Discovery Service Market Size by Application (2021-2026)
- 7.3.2 North America AI Drug Target Discovery Service Market Size by Application (2027-2032)
- 7.3.3 North America AI Drug Target Discovery Service Market Share by Application (2021-2032)
- 7.4 North America AI Drug Target Discovery Service Market Size by Country
- 7.4.1 North America AI Drug Target Discovery Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 7.4.3 North America AI Drug Target Discovery Service Market Size by Country (2027-2032)
- 7.4.4 North America AI Drug Target Discovery Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI Drug Target Discovery Service Market Size (2021-2032)
- 8.2 Europe AI Drug Target Discovery Service Market Size by Type
- 8.2.1 Europe AI Drug Target Discovery Service Market Size by Type (2021-2026)
- 8.2.2 Europe AI Drug Target Discovery Service Market Size by Type (2027-2032)
- 8.2.3 Europe AI Drug Target Discovery Service Market Share by Type (2021-2032)
- 8.3 Europe AI Drug Target Discovery Service Market Size by Application
- 8.3.1 Europe AI Drug Target Discovery Service Market Size by Application (2021-2026)
- 8.3.2 Europe AI Drug Target Discovery Service Market Size by Application (2027-2032)
- 8.3.3 Europe AI Drug Target Discovery Service Market Share by Application (2021-2032)
- 8.4 Europe AI Drug Target Discovery Service Market Size by Country
- 8.4.1 Europe AI Drug Target Discovery Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 8.4.3 Europe AI Drug Target Discovery Service Market Size by Country (2027-2032)
- 8.4.4 Europe AI Drug Target Discovery Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI Drug Target Discovery Service Market Size (2021-2032)
- 9.2 China AI Drug Target Discovery Service Market Size by Type
- 9.2.1 China AI Drug Target Discovery Service Market Size by Type (2021-2026)
- 9.2.2 China AI Drug Target Discovery Service Market Size by Type (2027-2032)
- 9.2.3 China AI Drug Target Discovery Service Market Share by Type (2021-2032)
- 9.3 China AI Drug Target Discovery Service Market Size by Application
- 9.3.1 China AI Drug Target Discovery Service Market Size by Application (2021-2026)
- 9.3.2 China AI Drug Target Discovery Service Market Size by Application (2027-2032)
- 9.3.3 China AI Drug Target Discovery Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI Drug Target Discovery Service Market Size (2021-2032)
- 10.2 Asia AI Drug Target Discovery Service Market Size by Type
- 10.2.1 Asia AI Drug Target Discovery Service Market Size by Type (2021-2026)
- 10.2.2 Asia AI Drug Target Discovery Service Market Size by Type (2027-2032)
- 10.2.3 Asia AI Drug Target Discovery Service Market Share by Type (2021-2032)
- 10.3 Asia AI Drug Target Discovery Service Market Size by Application
- 10.3.1 Asia AI Drug Target Discovery Service Market Size by Application (2021-2026)
- 10.3.2 Asia AI Drug Target Discovery Service Market Size by Application (2027-2032)
- 10.3.3 Asia AI Drug Target Discovery Service Market Share by Application (2021-2032)
- 10.4 Asia AI Drug Target Discovery Service Market Size by Country
- 10.4.1 Asia AI Drug Target Discovery Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 10.4.3 Asia AI Drug Target Discovery Service Market Size by Country (2027-2032)
- 10.4.4 Asia AI Drug Target Discovery Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI Drug Target Discovery Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Type
- 11.2.1 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI Drug Target Discovery Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Application
- 11.3.1 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI Drug Target Discovery Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Country
- 11.4.1 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI Drug Target Discovery Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI Drug Target Discovery Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst